Clinical Trial Update: Phase II Study of Remeron for Cancer Patients Losing More Than 10% of Their Body Weight [Phase 2]

View source ↗

Summary

A Phase II trial of mirtazapine (Remeron) for cancer cachexia in patients with advanced cancer was terminated, with results posted in December 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Cachexia

Drugs mentioned

• Remeron (mirtazapine)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Advanced Cancer | Phase 2 | Status: TERMINATED | Results posted: 2012-12-18